Back to Search Start Over

A novel deep intronic variant in LAMA2 identified by RNA sequencing.

Authors :
Djordjevic, Djurdja
Alawneh, Issa
Amburgey, Kimberly
Yuki, Kyoko E.
Kyriakopoulou, Lianna G
Navickiene, Vilma
Stavropoulos, Jim
Yoon, Grace
Dowling, James J
Gonorazky, Hernan
Source :
Neuromuscular Disorders. Jun2024, Vol. 39, p19-23. 5p.
Publication Year :
2024

Abstract

• LAMA2-related muscular dystrophy is caused by mutations of the alpha2 subunit of Laminin. • RNA sequencing is an increasingly utilized technique to directly analyze the transcriptome. • Homozygous deep intronic variant produces a novel splice junction in LAMA2 identified by RNA sequencing in keeping with LAMA2-related muscular dystrophy. LAMA2 -related muscular dystrophy is caused by pathogenic variants of the alpha2 subunit of Laminin. This common form of muscular dystrophy is characterized by elevated CK >1000IU/L, dystrophic changes on muscle biopsy, complete or partial absence of merosin staining, and both central and peripheral nervous system involvement. Advancements in genomic testing using NGS and wider application of RNA sequencing has expanded our knowledge of novel non-coding pathogenic variants in LAMA2. RNA sequencing is an increasingly utilized technique to directly analyze the transcriptome, through creation of a complementary DNA (cDNA) from the transcript within a tissue sample. Here we describe a homozygous deep intronic variant that produces a novel splice junction in LAMA2 identified by RNA sequencing analysis in a patient with a clinical phenotype in keeping with LAMA2 -related muscular dystrophy. Furthermore, in this case merosin staining was retained suggestive of a functional deficit. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09608966
Volume :
39
Database :
Academic Search Index
Journal :
Neuromuscular Disorders
Publication Type :
Academic Journal
Accession number :
177886027
Full Text :
https://doi.org/10.1016/j.nmd.2024.04.001